Abnormal expression or function of PTEN has been closely related to the occurrence and development of various malignant tumors, including endometrial, prostate, liver cancer, colorectal, breast, bladder, stomach, and lung cancers and leukemia (10–14, 19, 20, 22–25). The gene discussed is PTEN; the disease is lung carcinoma.